Bone marrow transplantation in hemophagocytic lymphohistiocytosis

Leukemia and Lymphoma

Volumn 41, Issue 1-2, 2001, Pages 89-95

  Durken M ^a   Finckenstein, F G ^a   Janka, G E ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Active disease; Bone marrow transplantation; Hemophagocytic lymphohistiocytosis; Treatment; Unrelated donors

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; ETOPOSIDE; FIBRINOGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METRONIDAZOLE; PROSTAVASIN; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

AIRWAY OBSTRUCTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOSOMAL RECESSIVE DISORDER; BLINDNESS; CAPILLARY LEAK SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOTHERAPY; CHIMERA; CLINICAL ARTICLE; DISEASE ACTIVITY; DONOR; FAMILIAL DISEASE; FEVER; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MORBIDITY; MUCOSA INFLAMMATION; NERVE CELL DIFFERENTIATION; PANCYTOPENIA; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RECURRENT DISEASE; RESPIRATORY TRACT INTUBATION; SEIZURE; SEPSIS; SIBLING; SPASTICITY; TREATMENT OUTCOME; VEIN OCCLUSION; VIRUS INFECTION;

EID: 0035069024     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057957     Document Type: Article

References (38)

1. Familial hemophagocytic lymphohistiocytosis
2. Haemophagocytic lymphohistiocytosis: Experience at two U.K. centers
3. Frequency and severity of central nervous system lesions in hemophagocytic lyphohistiocytosis
4. Cytokines in haemophagocytic syndrome
5. Diagnostic guidelines for hemphagocytic lymphohistiocytosis. The FHL study group of the Histiocyte Society
6. Hypercytokinema in familial hemophagocytic lymphohistiocytosis
7. Impaired natural killer cell activity in lymphohistiocytosis syndrome
8. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis
9. Genetic analysis of familial erythrophagocytic lymphohistiocytosis
10. Familial hemophagocytic lymphohistiocytosis
11. Localization of a gene for hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping
12. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity
13. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
14. Infection- and malignancy-associated hemophagocytic syndromes
15. Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock
16. Partial albinism with immunodeficiency (Griscelli syndrome)
17. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?
18. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance
19. Anaemia and thrombocytopenia due to haemophagocytosis in a 7-month-old boy with galactosialidosis
20. Methylmalonic acidaemia causing dyserythropoiesis and haemophagocytic bone marrow changes
21. Multiple sulphatase deficiency and haemophagocytic syndrome
22. Haemophagocytosis in hereditary fructose intolerance: A diagnostic dilemma
23. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society
24. Report of 122 children from the international registry
25. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis
26. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: A single-center study of 22 cases
27. Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation
28. Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden
29. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation
30. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors
31. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan
32. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients
33. The probability of finding a suitable related donor for bone marrow transplantation in extended families
34. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: A study in 136 children
35. Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis
36. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation
37. Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation